AAAAAA
Results:
1-13
|
Results: 13
Authors:
Limpert, J
Liem, A
Gabler, T
Zellmer, H
Tunnermann, A
Unger, S
Jetschke, S
Muller, HR
Citation: J. Limpert et al., High-average-power picosecond Yb-doped fiber amplifier, OPTICS LETT, 26(23), 2001, pp. 1849-1851
Authors:
Hofer, S
Liem, A
Limpert, J
Zellmer, H
Tunnermann, A
Unger, S
Jetschke, S
Muller, HR
Freitag, I
Citation: S. Hofer et al., Single-frequency master-oscillator fiber power amplifier system emitting 20 W of power, OPTICS LETT, 26(17), 2001, pp. 1326-1328
Authors:
Wang, BH
Robertson, BC
Girotto, JA
Liem, A
Miller, NR
Iliff, N
Manson, PN
Citation: Bh. Wang et al., Traumatic optic neuropathy: A review of 61 patients, PLAS R SURG, 107(7), 2001, pp. 1655-1664
Authors:
Nickel, D
Liem, A
Limpert, J
Zellmer, H
Griebner, U
Unger, S
Korn, G
Tunnermann, A
Citation: D. Nickel et al., Fiber based high repetition rate, high energy laser source applying chirped pulse amplification, OPT COMMUN, 190(1-6), 2001, pp. 309-315
Authors:
Frazer, IH
De Kluyver, R
Leggatt, GR
Guo, HY
Dunn, L
White, O
Harris, C
Liem, A
Lambert, P
Citation: Ih. Frazer et al., Tolerance or immunity to a tumor antigen expressed in somatic cells can bedetermined by systemic proinflammatory signals at the time of first antigen exposure, J IMMUNOL, 167(11), 2001, pp. 6180-6187
Authors:
Liem, A
Nickel, D
Limpert, J
Zellmer, H
Griebner, U
Unger, S
Tunnermann, A
Korn, G
Citation: A. Liem et al., High average power ultra-fast fiber chirped pulse amplification system, APP PHYS B, 71(6), 2000, pp. 889-891
Authors:
Liem, A
Zijlstra, F
Ottervanger, JP
Hoorntje, JCA
Suryapranata, H
de Boer, MJ
Verheugt, FWA
Citation: A. Liem et al., High dose heparin as pretreatment for primary angioplasty in acute myocardial infarction: The Heparin in Early Patency (HEAP) randomized trial, J AM COL C, 35(3), 2000, pp. 600-604
Authors:
Song, S
Liem, A
Miller, JA
Lambert, PF
Citation: S. Song et al., Human papillomavirus types 16 E6 and E7 contribute differently to carcinogenesis, VIROLOGY, 267(2), 2000, pp. 141-150
Authors:
Surh, YJ
Kim, SG
Liem, A
Lee, JW
Miller, JA
Citation: Yj. Surh et al., Inhibitory effects of isopropyl-2-(1,3-dithietane-2-ylidene)-2-[N-(4-methylthiazol-2-yl)carbamoyl]acetate (YH439) on benzo[a]pyrene-induced skin carcinogenesis and micronucleated reticulocyte formation in mice, MUT RES-F M, 423(1-2), 1999, pp. 149-153
Authors:
Liem, A
Zijlstra, F
Citation: A. Liem et F. Zijlstra, Transfer delay for primary PTCA: Does it influence clinical outcome? Reply, J AM COL C, 33(7), 1999, pp. 2088-2088
Authors:
Kim, SG
Liem, A
Stewart, BC
Miller, JA
Citation: Sg. Kim et al., New studies on trans-anethole oxide and trans-asarone oxide, CARCINOGENE, 20(7), 1999, pp. 1303-1307
Authors:
Ottervanger, JP
Liem, A
de Boer, MJ
van't Hof, AWJ
Suryapranata, H
Hoorntje, JCA
Zijlstra, F
Citation: Jp. Ottervanger et al., Limitation of myocardial infarct size after primary angioplasty: Is a higher potency the only mechanism?, AM HEART J, 137(6), 1999, pp. 1169-1172
Authors:
Griep, AE
Krawcek, J
Lee, D
Liem, A
Albert, DM
Carabeo, R
Drinkwater, N
McCall, M
Sattler, C
Lasudry, JGH
Lambert, PF
Citation: Ae. Griep et al., Multiple genetic loci modify risk for retinoblastoma in transgenic mice, INV OPHTH V, 39(13), 1998, pp. 2723-2732
Risultati:
1-13
|